ScholarIQanswers from OpenAlex
Baylor University
InstitutionResearch output, impact & collaborations
Baylor University is a institution indexed in ScholarIQ from OpenAlex.
What is known about Baylor University?
ScholarIQrecord summary
Baylor University is a research organisation in Waco, US. OpenAlex records 41,459 works and 2,647,328 citations for it. 8,352 researchers list it as their most recent affiliation.
How many works does Baylor University have?
ScholarIQindexed works
Baylor University has 41,459 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Baylor University have?
ScholarIQcitation count
Baylor University has 2,647,328 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Baylor University?
ScholarIQresearcher count
Baylor University has 8,352 researchers in the ScholarIQ index.
What is the average h-index at Baylor University?
ScholarIQavg h-index
Baylor University has an average h-index of 67.1 in OpenAlex.
What is the ROR of Baylor University?
ScholarIQror
The ROR for Baylor University is on the source record.
What is the OpenAlex record for Baylor University?
ScholarIQopenalex
The OpenAlex for Baylor University is on the source record.
What is the Wikidata of Baylor University?
ScholarIQwikidata
The Wikidata for Baylor University is on the source record.
Who are the most-cited researchers behind Baylor University?
ScholarIQtop researchers by citations
What are the most-cited papers on Baylor University?
ScholarIQmost cited works
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos, Ryan M Barber, Brad Bell, Amelia Bertozzi-Villa, Stan Biryukov, Ian Bolliger, Fiona Charlson, Adrian Davis, Louisa Degenhardt, Daniel Dicker, Leilei Duan, Holly E Erskine, Valery L. Feigin, Alize J Ferrari, Christina Fitzmaurice, Thomas Fleming, Nicholas Graetz, Caterina Guinovart, Juanita A. Haagsma, Gillian M Hansen, Sarah Wulf Hanson, Kyle R Heuton, Hideki Higashi, Nicholas J Kassebaum, Hmwe Hmwe Kyu, E Laurie, Xiofeng Liang, Katherine T Lofgren, Rafael Lozano, Michael F MacIntyre, Maziar Moradi‐Lakeh, Mohsen Naghavi, Grant Nguyen, Shaun Odell, Katrina Ortblad, D. Allen Roberts, Gregory A. Roth, Logan Sandar, Peter Serina, Jeffrey D Stanaway, Caitlyn Steiner, Bernadette Thomas, Stein Emil Vollset, Harvey Whiteford, Timothy M Wolock, Pengpeng Ye, Maigeng Zhou, Marco Antonio Navarrete Ávila, Gunn Marit Aasvang, Cristiana Abbafati, Ayşe Abbasoğlu Özgören, Foad Abd-Allah, Muna I. Abdel Aziz, Semaw Ferede Abera, Victor Aboyans, Jerry Abraham, Biju Abraham, Ibrahim Abubakar, Laith J. Abu‐Raddad, Niveen ME Abu-Rmeileh, Tania C. Aburto, Tom Achoki, Ilana N. Ackerman, Ademola Adelekan, Zanfina Ademi, Arsène Kouablan Adou, José Carmelo Adsuar, Johan Ärnlöv, Emilie Agardh, Mazin J Al Khabouri, Sayed Saidul Alam, Deena Alasfoor, Mohammed I Albittar, Miguel Alegretti, Alicia V Aleman, Zewdie Aderaw Alemu, Rafael Alfonso‐Cristancho, Samia Alhabib, Raghib Ali, François Alla, Peter Allebeck, Peter J. Allen, Mohammad AbdulAziz AlMazroa, Ubai Alsharif, Elena Álvarez, Nelson Alvis‐Guzmán, Omid Ameli, Heresh Amini, Walid Ammar, Benjamin O. Anderson, H Ross Anderson, Carl Abelardo T. Antonio, Palwasha Anwari, Henry Apfel, Valentain S Arsic Arsenijevic, Al Artaman, Rana J Asghar, Reza Assadi, Lydia S Atkins, Charles Atkinson
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid, Javier Cortés, Lajos Pusztai, Heather L. McArthur, Sherko Kümmel, Jonas Bergh, Carsten Denkert, Yeon Hee Park, Rina Hui, Nadia Harbeck, Masato Takahashi, Theodoros Foukakis, Peter A. Fasching, Fátima Cardoso, Michael Untch, Liyi Jia, Vassiliki Karantza, Jing Zhao, Gursel Aktan, Rebecca Dent, Joyce O’Shaughnessy
Global Distribution of Perfluorooctane Sulfonate in Wildlife
John P. Giesy, Kurunthachalam Kannan
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
William J. Gradishar, Sergei Tjulandin, Neville Davidson, Heather Shaw, Neil Desai, Paul Bhar, Michael Hawkins, Joyce O’Shaughnessy
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Gabriel N. Hortobágyi, Salomon M. Stemmer, Howard A. Burris, Yoon Sim Yap, Gabe S. Sonke, Shani Paluch–Shimon, Mario Campone, Kimberly Blackwell, Fabrice André, Eric P. Winer, Wolfgang Janni, Sunil Verma, PierFranco Conte, Carlos L. Arteaga, David Cameron, Katarína Petráková, Lowell L. Hart, Cristian Villanueva, Arlene Chan, Erik Jakobsen, Arnd Nusch, Olga Burdaeva, Eva‐Maria Grischke, Emilio Alba, Erik Wist, Norbert Marschner, Anne Favret, Denise A. Yardley, Thomas Bachelot, Ling-Ming Tseng, Sibel Blau, Fengjuan Xuan, Farida Souami, Michelle C. Miller, Caroline Germa, Samit Hirawat, Joyce O’Shaughnessy
How much of the research on Baylor University is open access?
ScholarIQopen access share
67%OPEN ACCESS